BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14981678)

  • 1. Uncertainty and the value of diagnostic information, with application to axillary lymph node dissection in breast cancer.
    Parmigiani G
    Stat Med; 2004 Mar; 23(5):843-55. PubMed ID: 14981678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast surgery and sentinel node biopsy. Our experience.
    Sanguinetti A; Sperlongano P; D'Ajello M; Pisaniello D; Piatto A; Misso C; Sordelli I; Monacelli M; Lucchini R; Parmeggiani D; Sperlongano R; Avenia N
    G Chir; 2006 Mar; 27(3):109-11. PubMed ID: 16681872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent cross-relaxation rate imaging of axillary lymph nodes in breast cancer.
    Mastsushima S; Nishiofuku H; Iwata H; Era S; Inaba Y; Kinosada Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1278-83. PubMed ID: 18504747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients.
    Carmon M; Hain D; Shapira J; Golomb E
    Breast J; 2006; 12(5):424-7. PubMed ID: 16958959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer of the axillary extension.
    Virgili A; Trincone S; Durante E; Corazza M
    Acta Derm Venereol; 2005; 85(1):81-2. PubMed ID: 15849004
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging.
    Ciatto S; Brancato B; Risso G; Ambrogetti D; Bulgaresi P; Maddau C; Turco P; Houssami N
    Breast Cancer Res Treat; 2007 May; 103(1):85-91. PubMed ID: 17033920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical rigour is essential to clinical prediction.
    Gebski VJ; Byth K; Langlands AO
    ANZ J Surg; 2007 Jul; 77(7):597-8; author reply 598-9. PubMed ID: 17610704
    [No Abstract]   [Full Text] [Related]  

  • 16. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
    Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
    Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic-assisted axillary dissection in breast cancer surgery.
    Lim SM; Lam FL
    Am J Surg; 2005 Oct; 190(4):641-3. PubMed ID: 16164939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy in elderly breast cancer patients.
    Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
    Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.